PPARG and serum lipopolysaccharide activity: Although these are animal studies and do not directly demonstrate involvement of either PPAR-γ or alveolar macrophages in the effects observed, they suggest that early treatment with PPAR-γ agonists could ameliorate the effects of endotoxemia, at least in the lung and probably elsewhere.